Low-dose gemcitabine plus cisplatin in previously treated, relapsed non-Hodgkin's lymphoma

被引:2
作者
Wong, SF [1 ]
Lindgren, T [1 ]
Hsu, D [1 ]
Tran, G [1 ]
机构
[1] Western Univ, Coll Pharm, Hematol Oncol Med Grp Orange Cty, Pomona, CA USA
关键词
D O I
10.1002/ajh.10349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:298 / 298
页数:1
相关论文
共 10 条
  • [1] Bergman AM, 1996, CLIN CANCER RES, V2, P521
  • [2] Boni C, 2000, INT J CANCER, V87, P724, DOI 10.1002/1097-0215(20000901)87:5<724::AID-IJC15>3.3.CO
  • [3] 2-E
  • [4] Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma
    Fosså, A
    Santoro, A
    Hiddemann, W
    Truemper, L
    Niederle, N
    Buksmaui, S
    Bonadonna, G
    Seeber, S
    Nowrousian, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3786 - 3792
  • [5] Time-intensified dexamethasone/cisplatin/cytarabine:: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease
    Josting, A
    Rudolph, C
    Reiser, M
    Mapara, M
    Sieber, M
    Kirchner, HH
    Dörken, B
    Hossfeld, DK
    Diehl, V
    Engert, A
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (10) : 1628 - 1635
  • [6] NAGOURNEY RA, 2003, GYNECOL ONCOL, V35, P88
  • [7] PETERS GJ, 1995, SEMIN ONCOL, V22, P72
  • [8] RESULTS OF A SALVAGE TREATMENT PROGRAM FOR RELAPSING LYMPHOMA - MINE CONSOLIDATED WITH ESHAP
    RODRIGUEZ, MA
    CABANILLAS, FC
    VELASQUEZ, W
    HAGEMEISTER, FB
    MCLAUGHLIN, P
    SWAN, F
    ROMAGUERA, JE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1734 - 1741
  • [9] Gemcitabine in the treatment of refractory Hodgkins's disease: Results of a multicenter phase II study
    Santoro, A
    Bredenfeld, H
    Devizzi, L
    Tesch, H
    Bonfante, V
    Viviani, S
    Fielder, F
    Parra, HS
    Benoehr, C
    Pacini, M
    Bonadonna, G
    Diehl, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) : 2615 - 2619
  • [10] Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: Experience in 44 patients
    Zinzani, PL
    Baliva, G
    Magagnoli, M
    Bendandi, M
    Modugno, G
    Gherlinzoni, F
    Orcioni, GF
    Ascani, S
    Simoni, R
    Pileri, SA
    Tura, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) : 2603 - 2606